Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Personal Web Page In Clinical Trial Participant Education
- Status
- COMPLETED
- Phase
- NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- NA
Individualizing Surveillance Mammography for Older Breast Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
- Status
- COMPLETED
- Phase
- NA
EHR-embedded OCDT in Breast or GI Cancer
- Status
- COMPLETED
- Phase
- NA
'ADVANCE' (A Pilot Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Symptom Management Implementation of Patient Reported Outcomes in Oncology
- Status
- COMPLETED
- Phase
- NA
Tucatinib + Abemaciclib + Herceptin for HER2+ MBC
- Status
- WITHDRAWN
- Phase
- PHASE1
A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance
- Status
- COMPLETED
- Phase
- N/A
Yoga for Painful Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized-Controlled Study
- Status
- COMPLETED
- Phase
- NA
Elevate! : An Elderly Breast Cancer Cohort Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial
- Status
- COMPLETED
- Phase
- NA
Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT
- Status
- TERMINATED
- Phase
- PHASE3
Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma
- Status
- TERMINATED
- Phase
- N/A
A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2)
- Status
- COMPLETED
- Phase
- PHASE1
GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE2